JP2024520205A5 - - Google Patents
Info
- Publication number
- JP2024520205A5 JP2024520205A5 JP2023571857A JP2023571857A JP2024520205A5 JP 2024520205 A5 JP2024520205 A5 JP 2024520205A5 JP 2023571857 A JP2023571857 A JP 2023571857A JP 2023571857 A JP2023571857 A JP 2023571857A JP 2024520205 A5 JP2024520205 A5 JP 2024520205A5
- Authority
- JP
- Japan
- Prior art keywords
- modified oligonucleotide
- nucleic acid
- modified
- oligomer compound
- oligomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163191905P | 2021-05-21 | 2021-05-21 | |
| US63/191,905 | 2021-05-21 | ||
| PCT/US2022/030335 WO2022246251A2 (en) | 2021-05-21 | 2022-05-20 | Compounds for modulating unc13a expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520205A JP2024520205A (ja) | 2024-05-22 |
| JP2024520205A5 true JP2024520205A5 (enExample) | 2025-05-26 |
Family
ID=84140868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571857A Pending JP2024520205A (ja) | 2021-05-21 | 2022-05-20 | Ｕｎｃ１３ａの発現を調節するための化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240301415A1 (enExample) |
| EP (1) | EP4341406A4 (enExample) |
| JP (1) | JP2024520205A (enExample) |
| WO (1) | WO2022246251A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2603454A (en) * | 2020-12-09 | 2022-08-10 | Ucl Business Ltd | Novel therapeutics for the treatment of neurodegenerative disorders |
| WO2023004049A1 (en) * | 2021-07-21 | 2023-01-26 | AcuraStem, Inc. | Unc13a antisense oligonucleotides |
| GB202117758D0 (en) * | 2021-12-09 | 2022-01-26 | Ucl Business Ltd | Therapeutics for the treatment of neurodegenerative disorders |
| JP2025500335A (ja) * | 2021-12-21 | 2025-01-09 | エフ． ホフマン－ラ ロシュ アーゲー | Ｕｎｃ１３ａを標的とするアンチセンスオリゴヌクレオチド |
| AU2023356317A1 (en) * | 2022-10-05 | 2025-05-15 | Trace Neuroscience, Inc. | Unc13a antisense oligonucleotides and uses thereof |
| WO2024178223A1 (en) * | 2023-02-24 | 2024-08-29 | Northwestern University | Antisense oligonucleotides for preventing unc13a misplicing |
| WO2024220746A2 (en) | 2023-04-21 | 2024-10-24 | Flagship Pioneering Innovations Vii, Llc | Rnai agents targeting fatty acid synthase and related methods |
| AU2024299328A1 (en) | 2023-07-21 | 2026-01-22 | Marrow Therapeutics, Inc. | Hematopoietic cell targeting conjugates and related methods |
| WO2025178854A2 (en) | 2024-02-19 | 2025-08-28 | Flagship Pioneering Innovations Vii, Llc | Rnai agents targeting cideb and related methods |
| US12612630B2 (en) | 2024-03-05 | 2026-04-28 | Takeda Pharmaceutical Company Limited | Compositions and methods for splicing modulation of UNC13A |
| WO2025217275A2 (en) | 2024-04-10 | 2025-10-16 | Flagship Pioneering Innovations Vii, Llc | Immune cell targeted compositions and related methods |
| WO2026080323A1 (en) * | 2024-10-09 | 2026-04-16 | Quralis Corporation | Treatment of neurological diseases using modulators of unc13a gene transcripts |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69435005T2 (de) * | 1993-05-11 | 2008-04-17 | The University Of North Carolina At Chapel Hill | Antisense Oligonukleotide die anomales Splicing verhindern und deren Verwendung |
| EP1470423A2 (en) * | 2001-11-05 | 2004-10-27 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Unc-13 in the modulation of neurotransmission and secretion events |
| AU2003295600A1 (en) * | 2002-11-14 | 2004-06-15 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| WO2005116204A1 (ja) * | 2004-05-11 | 2005-12-08 | Rnai Co., Ltd. | Ｒｎａ干渉を生じさせるポリヌクレオチド、および、これを用いた遺伝子発現抑制方法 |
| US20110195848A1 (en) * | 2010-01-08 | 2011-08-11 | Roopra Avtar S | Gene expression and breast cancer |
| US10517889B2 (en) * | 2017-09-08 | 2019-12-31 | Ionis Pharmaceuticals, Inc. | Modulators of SMAD7 expression |
| GB2603454A (en) * | 2020-12-09 | 2022-08-10 | Ucl Business Ltd | Novel therapeutics for the treatment of neurodegenerative disorders |
-
2022
- 2022-05-20 EP EP22805616.4A patent/EP4341406A4/en active Pending
- 2022-05-20 US US18/562,543 patent/US20240301415A1/en active Pending
- 2022-05-20 WO PCT/US2022/030335 patent/WO2022246251A2/en not_active Ceased
- 2022-05-20 JP JP2023571857A patent/JP2024520205A/ja active Pending